Q2 2019 13F Holders as of 6/30/2019
-
Type / Class
-
Equity / Class 'A' Ordinary Shares
-
Shares outstanding
-
386M
-
Number of holders
-
30
-
Total 13F shares, excl. options
-
11.8M
-
Shares change
-
-1.27M
-
Total reported value, excl. options
-
$20.2M
-
Value change
-
-$4.06M
-
Number of buys
-
8
-
Number of sells
-
-17
-
Price
-
$1.65
Significant Holders of Trinity Biotech plc - Class 'A' Ordinary Shares (TRIB) as of Q2 2019
36 filings reported holding TRIB - Trinity Biotech plc - Class 'A' Ordinary Shares as of Q2 2019.
Trinity Biotech plc - Class 'A' Ordinary Shares (TRIB) has 30 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 11.8M shares
of 386M outstanding shares and own 3.06% of the company stock.
Largest 10 shareholders include STONEHILL CAPITAL MANAGEMENT LLC (2.31M shares), Paradice Investment Management LLC (1.54M shares), HUNTER ASSOCIATES INVESTMENT MANAGEMENT LLC (1.43M shares), JANUS HENDERSON GROUP PLC (1.21M shares), HEARTLAND ADVISORS INC (885K shares), FIRST WILSHIRE SECURITIES MANAGEMENT INC (794K shares), RENAISSANCE TECHNOLOGIES LLC (685K shares), Lapides Asset Management, LLC (656K shares), Adirondack Research & Management Inc. (525K shares), and MORGAN STANLEY (461K shares).
This table shows the top 30 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.